Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 21, 2013; 19(43): 7671-7679
Published online Nov 21, 2013. doi: 10.3748/wjg.v19.i43.7671
Published online Nov 21, 2013. doi: 10.3748/wjg.v19.i43.7671
Figure 6 Serial changes of mean serum hepatitis B virus DNA levels.
Serum hepatitis B virus DNA levels decreased significantly not only from baseline to 12 wk but also from 12 wk to 24 wk in the LdT + ADV group. LAM: Lamivudine; ADV: Adefovire; HBV: High hepatitis B virus; LdT: Telbivudine.
- Citation: Park H, Park JY, Kim SU, Kim DY, Han KH, Chon CY, Ahn SH. Efficacy of switching to telbivudine plus adefovir in suboptimal responders to lamivudine plus adefovir. World J Gastroenterol 2013; 19(43): 7671-7679
- URL: https://www.wjgnet.com/1007-9327/full/v19/i43/7671.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i43.7671